Blog - Page 2971 of 5590

TuesdayMar 12, 2013 3:09 pm

VIASPACE, Inc. (VSPC) and the Applications of Giant King Grass

Giant King Grass (GKG) is a proprietary, dedicated biomass energy crop from VIASPACE that has the advantage of being the fastest growing and most cost-efficient energy crop available. By absorbing as much carbon during growth as is released when burned for energy, GKG offers a sound answer to the critical problem of greenhouse gases and global warming. As a dedicated biofuel, it avoids the cost and logistics problems inherent with waste bio sourcing, and the ability of GKG to grow in marginal conditions eliminates any threat to food crops or agricultural land. GKG is now beginning to be grown in…

TuesdayMar 12, 2013 2:23 pm

Advanced Cell Technology, Inc. (ACTC) CSO Dr. Lanza Named as One of “TOP 50 Global Stem Cell Influencers”

Advanced Cell Technology’s chief scientific officer Robert Lanza, M.D., has been ranked as one of the top four individuals featured on the "TOP 50 Global Stem Cell Influencers" list from Terrapinn's life sciences division, TotalBiopharma (“World Stem Cells & Regenerative Medicine Congress 2013”). The 50 individuals were chosen as the result of a global survey considering thousands of votes from participants within the stem cell community. The winners were selected based on their individual career achievements such as leading-edge research and discovery, innovation, or lifetime dedication. List sponsor Terrapinn likens the list to “Forbes [Celebrity] 100, but for stem cells.”…

TuesdayMar 12, 2013 12:11 pm

VistaGen Therapeutics, Inc. (VSTA) Secures Spot at World’s Premier Toxicology Conference to Present Latest Enhancements and Expanded Validation of LiverSafe 3D™

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, has been scheduled to present key enhancements to LiverSafe 3D™, its human liver cell-based bioassay system designed to predict liver toxicity and drug metabolism issues, in a poster presentation at the Society of Toxicology’s 52nd Annual Meeting today at 2:00pm EDT. Dr. Kristina Bonham, Senior Scientist, Hepatocyte Biology Project Leader, will present VistaGen’s poster entitled “Selection of CYP3A4+ hESC-derived Hepatocytes for Drug Metabolism and Toxicity Assays,” which will detail the following expanded data: • 3A4BLA-hepatocytes (human liver cells) can be used to:…

TuesdayMar 12, 2013 10:20 am

Got an iPad? GotStockTips? Get Both!

Every day hundreds of thousands in profits are made in the often ignored micro-cap markets. Unlike the blue-chips, micro-cap stocks can make rapid moves of 50% or more, making the latest information extremely critical to maximizing profits. GotStockTips delivers this crucial info to their subscribers in record time via instant text messaging and twitter. GotStockPicks recently announced that they will be giving away a free iPad to one of their subscribers. The winner will be announced via Twitter and FaceBook September 30, 2012. Sign up is free and easy. To learn more about the giveaway and sign up for your…

TuesdayMar 12, 2013 10:16 am

Neonode, Inc. (NEON) Multisensing™ Technology to be Used with Volvo’s Sensus Connected Touch

Neonode, a company developing optical touch technologies, has teamed up with Volvo Cars to integrate NEON’s Multisensing™ technology into the Swedish automaker’s new and connected infotainment device, the Sensus Connected Touch, a complete 7-inch touch panel operating on Google Android. NEON’s Multisensing touch solution meets all safety regulations and provides a 100 percent transparent, no-glare interface, enabling touch by any type of object, including gloved fingers or ordinary pens. The system features a built-in diagnostics that automatically alerts its operational status to other critical on-board systems. Thomas Eriksson, CEO at NEON noted the innovation of both companies’ products. "The fact…

TuesdayMar 12, 2013 9:19 am

iCAD, Inc. (ICAD) and Invivo Enter Global Strategic Agreement to Deliver MRI Solutions Across the Globe

Invivo, a Philips Healthcare Business and global leader in MRI technology, and iCAD, a prominent supplier of advanced imaging and radiation therapy technologies used in cancer detection and treatment, announced the development of a global research, development, and commercial agreement between the two companies. The agreement stipulates that iCAD will develop advanced MRI image analysis software products which will be integrated into Invivo’s portfolio of MRI product solutions for global commercial sale. The first products of the collaboration are expected to be available in Q2 2013. Next generation prostate and breast imaging will serve as the primary focus in the…

TuesdayMar 12, 2013 9:00 am

Viscount Systems, Inc. (VSYS) to Enhance Control Platform and Expand System Capabilities with Government Support

Viscount Systems, a leading-edge, high technology supplier of security systems and software, today announced that it has received conditional funding of up to $150,000 from the National Research Council of Canada Industrial Research Assistance Program (IRAP). IRAP support will be used to advance the development of Viscount’s Freedom access control platform and to expand system capabilities to a number of key areas, including mobile devices, preparing for U.S. Government full FICAM compliance, enhancing the Freedom Microsoft Active Directory platform, and enhanced encryption. “We are very pleased to have the support of the Industrial Research Assistance Program,” stated Stephen Pineau, President…

TuesdayMar 12, 2013 8:49 am

The Guitammer Company, Inc. (GTMM) Enhances Cash Flow by Modifying Terms of "Innovation Loan"

The Guitammer Company, a leader in low frequency sound and creator of the award-winning line of ButtKicker®-brand low frequency audio transducers that provide an immersive entertainment experience, announced this morning that The Director of the Ohio Development Services Agency and the company have entered into an agreement to modify its loan payment schedule. Previously scheduled to be due in full by July of 2014, the loan was modified to have a longer amortization timeframe. The modification was made to reduce Guitammer's monthly payment by approximately $16.5k per month for 2013 and by $14.6k per month for 2014 from the previous…

MondayMar 11, 2013 4:58 pm

ADVENTRX Pharmaceuticals, Inc. Officially Changes Name to Mast Therapeutics, Inc. (MSTX)

San Diego-based biopharmaceutical company ADVENTRX Pharmaceuticals announced today that its previously announced corporate name change has now gone into effect. The company’s name has now officially been changed to “Mast Therapeutics, Inc.” Effective at the opening of trading today, the company’s new ticker symbol is “MSTX.” Mast Therapeutics’ stock is listed on the NYSE MKT. Mast Therapeutics’ lead product candidate will be hereafter referred to as “MST-188” (formerly ANX-188). Additionally, a new CUSIP number, 576314 108, has been assigned to the company’s common stock. Outstanding stock certificates and warrants for shares of the company’s common stock have not been affected…

MondayMar 11, 2013 4:00 pm

International Stem Cell Corp. (ISCO) Subsidiary Uses Stem Cells to Reverse Effects of Aging

Lifeline Skin Care, a subsidiary of International Stem Cell Corporation, is focused on the development and marketing of the only skin care products in the world that are based upon non-embryonic human stem cell extracts. It is because of its relationship with ISCO that it has access to what are called parthenogenetic stem cells (hpSCs), stem cells that are unique in their qualities among all stem cell types. Although parthenogenetic stem cells have the potential to differentiate into various types of cell types, they do not require the use or destruction of a human embryo. They are generated using unfertilized…

Site Search

Company Search